Increased Risk for Invasive Group A Streptococcus Disease for Household Contacts of Scarlet Fever Cases, England, 2011-2016.
England
Streptococcus pyogenes
bacteria
household contacts
iGAS disease
incidence
invasive group A Streptococcus disease
respiratory infections
risk
scarlet fever
streptococcal infections
streptococci
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
pubmed:
3
1
2019
medline:
16
8
2019
entrez:
3
1
2019
Statut:
ppublish
Résumé
The incidence of scarlet fever in England and Wales is at its highest in 50 years. We estimated secondary household risk for invasive group A Streptococcus (iGAS) disease within 60 days after onset of scarlet fever. Reports of scarlet fever in England during 2011-2016 were matched by residential address to persons with laboratory-confirmed iGAS infections. We identified 11 iGAS cases in ≈189,684 household contacts and a 60-day incidence rate of 35.3 cases/100,000 person-years, which was 12.2-fold higher than the background rate (2.89). Infants and contacts >75 years of age were at highest risk. Three cases were fatal; sepsis and cellulitis were the most common manifestations. Typing for 6 iGAS cases identified emm 1.0 (n = 4), emm 4.0 (n = 1), and emm 12.0 (n = 1). Although absolute risk in household contacts was low, clinicians assessing household contacts should be aware of the risk to expedite diagnosis and initiate life-saving treatment.
Identifiants
pubmed: 30602121
doi: 10.3201/eid2503.181518
pmc: PMC6390732
doi:
Types de publication
Historical Article
Journal Article
Langues
eng
Pagination
529-537Subventions
Organisme : Medical Research Council
ID : MR/P022669/1
Pays : United Kingdom
Références
Scand J Infect Dis. 1997;29(3):239-44
pubmed: 9255882
Microb Genom. 2016 Jun 24;2(6):e000059
pubmed: 28348855
Lancet Infect Dis. 2018 Feb;18(2):180-187
pubmed: 29191628
Emerg Infect Dis. 2012 Oct;18(10):1658-61
pubmed: 23018120
Euro Surveill. 2014 Mar 27;19(12):20749
pubmed: 24698137
EBioMedicine. 2018 Feb;28:128-135
pubmed: 29342444
BMC Infect Dis. 2006 Aug 16;6:130
pubmed: 16914034
BMC Genomics. 2017 Mar 10;18(1):224
pubmed: 28283023
Epidemiol Infect. 2015 Jun;143(8):1719-30
pubmed: 25262779
Clin Otolaryngol. 2018 Jun;43(3):912-919
pubmed: 29505705
Clin Infect Dis. 2015 Jan 1;60(1):166-7
pubmed: 25258351
Lancet Infect Dis. 2018 Sep;18(9):942
pubmed: 30152353
MMWR Morb Mortal Wkly Rep. 1997 Oct 10;46(40):944-8
pubmed: 9338455
J Infect. 2012 Jan;64(1):1-18
pubmed: 22120112
Emerg Infect Dis. 2008 Feb;14(2):202-9
pubmed: 18258111
J Hosp Infect. 2014 Jul;87(3):141-4
pubmed: 24928787
Commun Dis Public Health. 2004 Dec;7(4):354-61
pubmed: 15786581
Infect Immun. 2014 Mar;82(3):1141-6
pubmed: 24371220
Epidemiol Infect. 2017 Oct;145(13):2759-2765
pubmed: 28805176
Lancet Infect Dis. 2018 Aug;18(8):823-824
pubmed: 29858151
Clin Microbiol Infect. 2003 Jun;9(6):554-9
pubmed: 12848734
Open Forum Infect Dis. 2018 Jul 20;5(8):ofy177
pubmed: 30109241
Paediatr Child Health. 1999 Jan;4(1):73-82
pubmed: 20212993
J Hosp Infect. 1995 Jun;30(2):162-4
pubmed: 7673692
J Pediatric Infect Dis Soc. 2014 Dec;3(4):336-42
pubmed: 26625454
Arch Dis Child. 1945 Mar;20(101):2-21
pubmed: 21032289
Euro Surveill. 2017 May 11;22(19):
pubmed: 28537550